Fig. 8From: Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivoPercentage of a CD4 +/CD3 + and (B) CD8 +/CD3 + T-cell population from spleenocytes of normal, negative control, AF2240-i, and rAF-IL12 groups after 28 days of treatment as analysed by flow cytometry. Data are presented as mean ± S.E.M. of six mice per group. Mean values with statistical difference at p ≤ 0.05 between groups are indicated with *Back to article page